Here, we explain the clinical and pathological features of SSc and introduce these cytokines, with a focus on the proinflammatory cytokine interleukin (IL)-6 and the fibrosis-related cytokines IL-13 and transforming growth factor (TGF)-β. This evidence concerns the gene TGFB1 and systemic sclerosis.